Shen Wang

This publication record appears to span a mix of molecular biology and biochemistry topics, including RNA modification (such as m6A/METTL16), cancer-related gene expression (e.g., prostate cancer, glioblastoma), bone/muscle biology, chemical synthesis, and computational protein structure prediction tools like AlphaFold. The breadth of subject matter and venues suggests the name 'Shen Wang' may correspond to multiple distinct researchers or collaborative contributions across very different subfields rather than one tightly focused research program. Prospective students should note the topic diversity may reflect shared authorship of a common name rather than a single coherent research direction.

Publication output was low and sporadic from 2017–2021, rose sharply to a peak in 2022–2023, and has since settled into a moderate, steady pace through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026